Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.20.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 5,498 $ 5,223
Receivables 1,061 993
Inventory 969 998
Prepaid expenses and other current assets 1,162 1,094
Total current assets 8,690 8,308
Property and equipment, net 799 817
Operating lease right-of-use asset 273 397
Total assets 9,762 9,522
Current liabilities:    
Accounts payable 1,528 1,401
Accrued clinical trials expenses 275 309
Accrued sales allowances 64 809
Other accrued liabilities 1,074 809
Operating lease liability, current 292 272
Current portion of long-term debt 1,624 0
Total current liabilities 4,857 3,600
Operating lease liability, non-current 0 150
Long-term debt 3,345 4,019
Warrant liability 0 320
Total liabilities 8,202 8,089
Stockholders' equity:    
Common stock, at amounts paid-in 97 57
Additional paid-in capital 360,725 350,413
Accumulated deficit (359,262) (349,037)
Total stockholders' equity 1,560 1,433
Total liabilities and stockholders' equity $ 9,762 $ 9,522